Research Article
MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
Table 1
Patient demographics.
| | | MPM () | BAPE () |
| | Age, y ± SD (range) | 68.0 ± 7.5 (48–81) | 65.7 ± 12.3 (49–79) | | Sex, male : female | 9 : 9 | 5 : 1 | | Asbestos exposure time, | 33.1 ± 19.6 (0–81) | 28.2 ± 11.3 (20–49) | | y ± SD (range) | | | | Histology, (%) | | | | Epithelial | 10 (55.6) | — | | Mixed | 4 (22.2) | | Sarcomatoid | 4 (22.2) | | Stage, (%) | | | | I-II | 4 (22.2) | — | | III-IV | 14 (77.8) | | Treatment, (%) | | | | Yes | 11 (61.1) | — | | No | 7 (38.9) |
|
|
MPM: malignant pleural mesothelioma; BAPE: benign asbestos-related pleural effusion; SD: standard deviation.
|
